| 04/05/2026 11:15 PM | Aardvark Therapeutics (1774857) Filer | Form EFFECT | |
| 04/03/2026 3:05 PM | Aardvark Therapeutics (1774857) Filer | Form 424B5 | |
| 03/23/2026 4:10 PM | Aardvark Therapeutics (1774857) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 03/23/2026 3:19 PM | Aardvark Therapeutics (1774857) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/23/2026 3:09 PM | Aardvark Therapeutics (1774857) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/12/2026 7:17 AM | Aardvark Therapeutics (1774857) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 8:00 PM | Aardvark Therapeutics (1774857) Issuer Lee Tien-Li (1940120) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 8:00 PM | Aardvark Therapeutics (1774857) Issuer Jaiman Manasi (2045686) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 8:00 PM | Aardvark Therapeutics (1774857) Issuer Sun Nelson (2045377) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/10/2026 7:14 AM | Aardvark Therapeutics (1774857) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 7:30 AM | Aardvark Therapeutics (1774857) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/12/2025 7:30 PM | Aardvark Therapeutics (1774857) Issuer Lee Tien-Li (1940120) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/12/2025 7:30 PM | Aardvark Therapeutics (1774857) Issuer Sun Nelson (2045377) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/10/2025 3:54 PM | Aardvark Therapeutics (1774857) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/16/2025 5:12 PM | Aardvark Therapeutics (1774857) Issuer Jones Bryan (2045615) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/16/2025 5:14 PM | Aardvark Therapeutics (1774857) Issuer Lee Tien-Li (1940120) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2025 5:15 AM | Aardvark Therapeutics (1774857) Issuer Lee Tien-Li (1940120) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2025 3:05 PM | Aardvark Therapeutics (1774857) Subject Tan Finian (2057336) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/12/2025 7:28 PM | Aardvark Therapeutics (1774857) Issuer Lee Tien-Li (1940120) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2025 4:36 PM | Aardvark Therapeutics (1774857) Issuer Sun Nelson (2045377) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2025 7:56 PM | Aardvark Therapeutics (1774857) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/29/2025 3:05 PM | Aardvark Therapeutics (1774857) Issuer Lee Tien-Li (1940120) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/28/2025 3:36 PM | Aardvark Therapeutics (1774857) Subject Tan Finian (2057336) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/13/2025 4:29 PM | Aardvark Therapeutics (1774857) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |